Samuel N. Hazen is CEO at HCA INC/TN (HCA). They have made 7 open-market trades across 1 company since 2011, most recently 2026-02-10.
CIK 0001216838
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCA | 86,165 | $44.0M |
| PrivateUnlisted | 35,031 | — |
| Total | $44.0M |
Shares reported on the most recent Form 4, priced at the 2026-02-12 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCA | SELL | 2026-02-03 | 2026-02-05 | $501.04 | $21.5M | +4.1% | +6.1% | -16.4% |
| HCA | SELL | 2021-11-02 | 2021-11-02 | $251.73 | $25.2M | -0.8% | -6.1% | -2.9% |
| HCA | SELL | 2020-11-03 | 2020-11-05 | $135.59 | $32.4M | +11.4% | +13.1% | +26.1% |
| HCA | SELL | 2018-01-31 | 2018-02-02 | $100.47 | $5.6M | +1.0% | +2.2% | -3.1% |
| HCA | SELL · 10b5-1 | 2015-04-15 | 2015-04-17 | $80.00 | $14.4M | -1.1% | +0.9% | +0.9% |
| HCA | SELL · 10b5-1 | 2014-12-23 | 2014-12-29 | $75.00 | $13.5M | -1.1% | +0.9% | +0.9% |
| HCA | SELL | 2014-08-04 | 2014-08-06 | $66.00 | $1.3M | -1.1% | +0.9% | +0.9% |
| HCA | SELL | 2014-02-07 | 2014-02-07 | $48.00 | $1.4M | -1.1% | +0.9% | +0.9% |
| HCA | SELL | 2011-03-15 | 2011-03-17 | $28.91 | $2.2M | -1.1% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.